0.3946
                                            Schlusskurs vom Vortag:
              $0.3933
            Offen:
              $0.382
            24-Stunden-Volumen:
                810.73K
            Relative Volume:
              1.09
            Marktkapitalisierung:
                $16.53M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-17.78M
            KGV:
              -0.7185
            EPS:
                -0.5492
            Netto-Cashflow:
                $-10.52M
            1W Leistung:
              -8.83%
            1M Leistung:
              -28.15%
            6M Leistung:
                -60.93%
            1J Leistung:
              -87.59%
            Fibrobiologics Inc Stock (FBLG) Company Profile
Firmenname
                  
                      Fibrobiologics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      281-671-5150
                    
                Adresse
                  
                      455 E. MEDICAL CENTER BLVD, HOUSTON
                    
                Vergleichen Sie FBLG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                FBLG
                            
                             
                        Fibrobiologics Inc 
                           | 
                    0.3946 | 16.47M | 0 | -17.78M | -10.52M | -0.5492 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2024-12-12 | Eingeleitet | Rodman & Renshaw | Buy | 
| 2024-10-30 | Eingeleitet | H.C. Wainwright | Buy | 
| 2024-09-24 | Eingeleitet | Maxim Group | Buy | 
Fibrobiologics Inc Aktie (FBLG) Neueste Nachrichten
Should you hold or exit FibroBiologics Inc. nowLayoff News & Smart Allocation Stock Reports - newser.com
How FibroBiologics Inc. stock performs in interest rate cycles2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Is FibroBiologics Inc. (SG0) stock included in top ETFs2025 Macro Impact & Technical Confirmation Alerts - newser.com
D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
What’s the recovery path for long term holders of FibroBiologics Inc.Trade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com
When is the best time to exit FibroBiologics Inc.2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
How sustainable is FibroBiologics Inc. stock dividend payoutLayoff News & Accurate Intraday Trading Signals - newser.com
FBLG Analyst Ratings: Jason Kolbert Maintains Buy Stance | FBLG Stock News - GuruFocus
Is FibroBiologics Inc. (SG0) stock ideal for retirement investorsJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Is FibroBiologics Inc. (SG0) stock resilient in recession scenariosDividend Hike & Smart Allocation Stock Reports - newser.com
How dovish Fed policy supports FibroBiologics Inc. (SG0) stockWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Identifying reversal signals in FibroBiologics Inc.Weekly Profit Report & Community Verified Trade Signals - newser.com
Sector ETF performance correlation with FibroBiologics Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
How FibroBiologics Inc. (SG0) stock performs in easing cyclesTrend Reversal & Safe Capital Growth Trade Ideas - newser.com
What earnings revisions data tells us about FibroBiologics Inc.Market Performance Summary & Capital Protection Trade Alerts - newser.com
Real time scanner hits for FibroBiologics Inc. explainedStock Surge & Free Technical Confirmation Trade Alerts - newser.com
Analyzing recovery setups for FibroBiologics Inc. investorsQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
What data driven models say about FibroBiologics Inc.’s futureTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why institutional investors increase stakes in FibroBiologics Inc. (SG0) stock2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
FibroBiologics, Inc. (FBLG) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What drives FibroBiologics Inc stock priceTrading Volume Surges & Free Tools to Monitor Market Corrections - earlytimes.in
FibroBiologics Advances Manufacturing and IND Preparations for Clinical Trials of CYWC628, CYPS317, and CYMS101 - Quiver Quantitative
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics, Inc. SEC 10-Q Report - TradingView
FibroBiologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
FibroBiologics warns on going concern amid $15M notes - Stock Titan
Is FibroBiologics Inc. stock gaining market shareMarket Activity Recap & Precise Buy Zone Tips - newser.com
Finanzdaten der Fibrobiologics Inc-Aktie (FBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):